{"id":"https://openalex.org/W50857992","doi":null,"title":"Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.","display_name":"Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.","publication_year":2006,"publication_date":"2006-02-01","ids":{"openalex":"https://openalex.org/W50857992","mag":"50857992","pmid":"https://pubmed.ncbi.nlm.nih.gov/16449961"},"language":"en","primary_location":{"id":"pmid:16449961","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16449961","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical science monitor : international medical journal of experimental and clinical research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006110702","display_name":"Ebrahim A. Balbisi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142823887","display_name":"St. John's University","ror":"https://ror.org/00bgtad15","country_code":"US","type":"education","lineage":["https://openalex.org/I142823887"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ebrahim A Balbisi","raw_affiliation_strings":["Department of Clinical Pharmacy Practice, College Of Pharmacy & Allied Health Professions, St. John's University, New York, NY, USA. balbisie@stjohns.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy Practice, College Of Pharmacy & Allied Health Professions, St. John's University, New York, NY, USA. balbisie@stjohns.edu","institution_ids":["https://openalex.org/I142823887"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5006110702"],"corresponding_institution_ids":["https://openalex.org/I142823887"],"apc_list":null,"apc_paid":null,"fwci":1.1323,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.79910446,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"12","issue":"2","first_page":"RA34","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperlipidemia-management","display_name":"hyperlipidemia management","score":0.968999981880188},{"id":"https://openalex.org/keywords/ldl-cholesterol-targets","display_name":"LDL cholesterol targets","score":0.8460000157356262},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.5899999737739563},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.7490000128746033},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.9380000233650208},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.8679999709129333},{"id":"https://openalex.org/keywords/ncep-guidelines","display_name":"NCEP guidelines","score":0.7910000085830688},{"id":"https://openalex.org/keywords/high-risk-patients","display_name":"high-risk patients","score":0.7919999957084656},{"id":"https://openalex.org/keywords/cholesterol-lowering-therapy","display_name":"cholesterol-lowering therapy","score":0.621999979019165},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.3720000088214874}],"concepts":[{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.8532602190971375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7698825597763062},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5732690095901489},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.560105562210083},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5174808502197266},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.485588014125824},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4799785315990448},{"id":"https://openalex.org/C2778402494","wikidata":"https://www.wikidata.org/wiki/Q599756","display_name":"National Cholesterol Education Program","level":4,"score":0.45317110419273376},{"id":"https://openalex.org/C2982889124","wikidata":"https://www.wikidata.org/wiki/Q107439039","display_name":"Disease management","level":4,"score":0.4307101368904114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4244599938392639},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.14196273684501648},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1334025263786316},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.11194208264350891},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.09216034412384033},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069438","descriptor_name":"Ezetimibe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D002792","descriptor_name":"Cholestyramine Resin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002995","descriptor_name":"Clofibric Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008019","descriptor_name":"Life Style","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D009525","descriptor_name":"Niacin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16449961","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16449961","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical science monitor : international medical journal of experimental and clinical research","raw_type":"Journal Article"},{"id":"mag:50857992","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16449961","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2134498866","https://openalex.org/W2468078881","https://openalex.org/W2400233210","https://openalex.org/W2396705073","https://openalex.org/W2418375869","https://openalex.org/W2022884334","https://openalex.org/W2404855757","https://openalex.org/W2027284937","https://openalex.org/W2057692952","https://openalex.org/W149207353"],"abstract_inverted_index":{"Coronary":[0],"heart":[1],"disease":[2],"(CHD)":[3],"remains":[4],"the":[5,11,26,34,39,47,55,72,101,113,121,125,134,148,151,187,192,206,214,220],"leading":[6],"cause":[7],"of":[8,28,36,41,49,74,82,103,115,124,147,153,175,194,205,216],"mortality":[9,227],"in":[10,33,78,95,156],"United":[12],"States,":[13],"and":[14,38,108,170,226],"is":[15,131,150,164,171,199],"associated":[16,228],"with":[17,69,229],"significant":[18],"health":[19,188],"care":[20,189],"costs.":[21],"Current":[22],"evidence":[23,64],"overwhelmingly":[24],"confirms":[25],"role":[27],"low-density":[29],"lipoprotein":[30],"cholesterol":[31,68,84],"(LDL-C)":[32],"pathogenesis":[35],"atherosclerosis":[37],"risk":[40,73],"CHD":[42,142],"events.":[43],"The":[44,86,98,117,180],"approach":[45,137],"to":[46,138,159,186,201,219],"management":[48,114,215],"hyperlipidemia":[50],"has":[51],"evolved":[52],"dramatically":[53],"over":[54],"past":[56],"decade.":[57],"Randomized":[58],"clinical":[59,106,178],"trails":[60],"have":[61],"provided":[62,109,165],"strong":[63],"that":[65],"lowering":[66],"plasma":[67],"statins":[70],"reduces":[71],"cardiovascular":[75],"events,":[76],"particularly":[77],"high-risk":[79,157],"patients,":[80],"irrespective":[81],"baseline":[83],"levels.":[85],"National":[87],"Cholesterol":[88],"Education":[89],"Program":[90],"(NCEP)":[91],"report":[92,99,118,149],"was":[93],"released":[94],"July":[96],"2004.":[97],"examined":[100],"results":[102],"recently":[104,176],"concluded":[105,177],"trials":[107],"consensus":[110],"recommendations":[111,183,221],"on":[112,120,173],"hyperlipidemia.":[116,217],"expands":[119],"core":[122],"content":[123],"previously":[126],"published":[127],"guidelines.":[128],"However,":[129],"it":[130],"by":[132],"far":[133],"most":[135],"aggressive":[136,182],"date":[139],"for":[140,212],"reducing":[141],"risk.":[143],"A":[144],"focal":[145],"element":[146],"modification":[152],"LDL-C":[154],"goal":[155,163],"patients":[158,195],"<70":[160],"mg/dL.":[161],"This":[162],"as":[166,191],"a":[167],"therapeutic":[168],"option":[169],"based":[172],"findings":[174],"trials.":[179],"more":[181],"add":[184],"challenges":[185],"system,":[190],"number":[193],"requiring":[196],"drug":[197],"therapy":[198],"likely":[200],"increase.":[202],"In":[203],"spite":[204],"challenges,":[207],"there":[208],"are":[209],"ample":[210],"opportunities":[211],"improving":[213],"Adherence":[218],"will":[222],"vastly":[223],"reduce":[224],"morbidity":[225],"CHD.":[230]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}